36 min listen
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
ratings:
Length:
56 minutes
Released:
Apr 3, 2023
Format:
Podcast episode
Description
Today's episode of the Business of Biotech covers a lot of ground with Enzyvant CEO Bill Symonds, Pharm.D. Among other things, we discuss the career moves Dr. Symonds has made within the "vant" environment since his involvement in the launch of the original Roivant, the approval of Rethymic, the merger of Altavant and Enzyvant, and the company's intentions for a brand new regenerative medicine manufacturing facility in Research Triangle Park. From drug approvals to mergers, from internal manufacturing capacity to founders-turned-presidential candidates, this one's got it all. Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!
Released:
Apr 3, 2023
Format:
Podcast episode
Titles in the series (100)
005: Building A Biotech All-Star Team With Vivek Ramaswamy by Business Of Biotech